The University of Kansas Medical Center's Divisions of Medical Oncology and Hematologic Malignancy and Cellular Therapeutics (HMCT) offer a comprehensive, ACGME-accredited three-year combined fellowship. Upon successful completion, fellows are board-eligible in both Hematology and Medical Oncology.
Our program maintains a robust partnership with the Kansas City Veterans Affairs Medical Center, where fellows complete 25% of their training. In July 2025, we expanded our clinical sites to include Olathe Medical Center. This expansion increases our annual intake to six fellows and introduces a dedicated Community Oncology Track for those pursuing careers in private or community-based clinical practice. This track is listed independently in the National Resident Matching Program (NRMP) as community track.
Clinical Training and Specialization
The curriculum provides rigorous training across diverse inpatient and outpatient settings. We emphasize a multidisciplinary, evidence-based approach to patient care, with a particular focus on longitudinal continuity clinic. Fellows are integrated into specialty-driven continuity clinics to foster clinical independence and "ownership" of patient management which are guided by subspecialty focused faculty.
Rotations are led by nationally recognized faculty at the University of Kansas Cancer Center, an NCI-Designated Comprehensive Cancer Center consistently ranked among the nation's elite by U.S. News & World Report. Fellows gain hands-on experience in one of the country's premier hematopoietic stem cell transplant and cellular therapeutics programs, alongside specialized training in cancer prevention, survivorship and early-phase drug development clinical trials.
Academic Tracks and Research
Candidates must select one of the two specialized tracks at the time of rank order list submission:
- Clinical Research Track: Designed for those pursuing academic medicine. Fellows actively contribute to scholarly inquiry, including the development of clinical trial protocols.
- Community Track: Tailored for clinical excellence in community settings, with 20% training dedicated to the Olathe Medical Center campus.
Physician-Scientist Training Program (PSTP): For candidates committed to research including basic or translational research, the ABIM Research Pathway is available. This program offers a compressed clinical schedule to prioritize research-based career development, it is subject to funding and candidate eligibility. For more details, follow the link
- KU Medical Center American Board of Internal Medicine (ABIM) Research Pathway
- ABIM Careers in Basic Science or Clinical Research
Unique Elective Opportunities
Beyond standard rotations in palliative care, radiation oncology, and pathology, the program offers specialized "out-of-site" electives:
- Rural Oncology: A one-month rotation in rural Kansas focused on the unique challenges of regional cancer care.
- Global Oncology: A one-month international elective in resource-constrained environments to broaden perspectives on global health disparities.
Leadership and Faculty
Our faculty are active participants in major national cooperatives, including SWOG Cancer Research Network, NRG Oncology, and ASBMT. Research interests span Phase I-III clinical trials, survivorship, and translational science.
Program Leadership
- Prakash Neupane, M.D., FASCO | Professor of Medicine; Program Director
- Heather Male, M.D. | Professor of Medicine; Associate Program Director
- Cheryl Jacobson – Program Coordinator (email: cjacobson@kumc.edu; office: 913-588-0348).